CHEMOTHERAPY PAYMENTS: Drug Payments For These Commonly Prescribed Drugs Drop Up To 38 Percent In July

Article Overview

This article covers CMS’s July 2005 updates to Medicare drug payment amounts for commonly used chemotherapy drugs and the broader context of ASP-based pricing changes. It is aimed at oncology practices, reimbursement staff, and coding/billing professionals who need to understand how the updated payment environment may affect physician-administered drug reimbursement. The discussion focuses on general payment trends, CMS’s rationale, and practice-level implications without providing detailed coding instructions.